Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

Biodegradable Long-Circulating Polymeric Nanospheres

Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,924 · see citing works

Encyclopedia of Nanoscience and Nanotechnology

(2013) · Chemical & Engineering News · doi:10.1021/cen-09136-ad11 · Cited by 2,546 · see citing works

A good practice guide to the administration of substances and removal of blood, including routes and volumes

Diehl, K., Hull, R., Morton, D. B., Pfister, R., Rabemampianina, Y., Smith, D. W., Vidal, J., & Vorstenbosch, C. V. D. (2001) · Journal of Applied Toxicology · doi:10.1002/jat.727 · Cited by 1,570 · see citing works

Nanoparticles as drug delivery systems

Wilczewska, A. Z., Niemirowicz, K., Markiewicz, K. H., & Car, H. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70901-5 · Cited by 1,445 · see citing works

Convection-enhanced delivery of macromolecules in the brain.

Bobo, R. H., Laske, D. W., Akbaşak, A., Morrison, P. F., Dedrick, R. L., & Oldfield, E. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2076 · Cited by 1,414 · see citing works

Nanoparticulate systems for brain delivery of drugs.

Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · see citing works

Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects

Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 997 · see citing works

Nanoparticulate systems for brain delivery of drugs

Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958 · see citing works

Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases

Gabathuler, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 804 · see citing works

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801 · see citing works

Transport of drugs across the blood–brain barrier by nanoparticles.

Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715 · see citing works

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities

Begley, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.001 · Cited by 679 · see citing works

Chitosan Nanoparticles: A Promising System in Novel Drug Delivery

Nagpal, K., Singh, S. K., & Mishra, D. N. (2010) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.58.1423 · Cited by 661 · see citing works

<i>In vivo</i> diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space

Thorne, R. G., & Nicholson, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509425103 · Cited by 641 · see citing works

Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System

Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635 · see citing works

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)

Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591 · see citing works

Polymeric nanoparticles for drug delivery to the central nervous system

Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 569 · see citing works

Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery

Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 567 · see citing works

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538 · see citing works

Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521 · see citing works

Delivery of peptides and proteins through the blood–brain barrier

Bickel, U., Yoshikawa, T., & Pardridge, W. M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00139-3 · Cited by 482 · see citing works

Colloidal Drug Delivery Systems

Kreuter, J. (2014) · CRC Press eBooks · doi:10.1201/9781498710565 · Cited by 472 · see citing works

Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles

Kreuter, J., Ramge, P., Petrov, V. E., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R. N., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469 · see citing works

Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.

Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443 · see citing works

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438 · see citing works

Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles

Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, E. S., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434 · see citing works

Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery

Kim, D., & Martin, D. C. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.12.021 · Cited by 432 · see citing works

Colloidal drug delivery systems

Duncan‐Hewitt, W. C. (1995) · Colloids and Surfaces B Biointerfaces · doi:10.1016/0927-7765(95)90010-1 · Cited by 419 · see citing works

Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease

Roney, C. A., Kulkarni, P. V., Arora, V., Antich, P. P., Bonte, F. J., Wu, A., Mallikarjuana, N. N., Manohar, S. K., Liang, H., Kulkarni, A. R., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.024 · Cited by 408 · see citing works

Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease

Mathew, A., Fukuda, T., Nagaoka, Y., Hasumura, T., Morimoto, H., Yoshida, Y., Maekawa, T., Venugopal, K., & Kumar, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032616 · Cited by 399 · see citing works

Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma

Xin, H., Jiang, X., Gu, J., Sha, X., Chen, L., Law, K., Chen, Y., Wang, X., Jiang, Y., & Fang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.044 · Cited by 384 · see citing works

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease

Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., & Suresh, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.039 · Cited by 363 · see citing works

Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles

Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352 · see citing works

Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain

Michaelis, K., Hoffmann, M. M., Dreis, S., Herbert, E., Alyautdin, R. N., Michaelis, M., Kreuter, J., & Langer, K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097139 · Cited by 346 · see citing works

Colloidal carriers and blood–brain barrier (BBB) translocation: A way to deliver drugs to the brain?

García-García, E., Andrieux, K., Gil, S., & Couvreur, P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.031 · Cited by 314 · see citing works

TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs

Rao, K. S., Reddy, M. K., Horning, J. L., & Labhasetwar, V. D. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.004 · Cited by 314 · see citing works

Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles

Xin, H., Sha, X., Jiang, X., Zhang, W., Chen, L., & Fang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.046 · Cited by 311 · see citing works

Pharmacokinetics and distribution of a biodegradable drug-carrier

Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Campeneere, D. D.-D., & Speiser, P. P. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90166-7 · Cited by 305 · see citing works

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactants

Petri, B., Bootz, A., Khalansky, A. S., Hekmatara, T., Müller, R. H., Uhl, R., Kreuter, J., & Gelperina, S. E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.015 · Cited by 299 · see citing works

Targeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides

Li, J., Feng, L., Fan, L., Zha, Y., Guo, L., Zhang, Q., Chen, J., Pang, Z., Wang, Y., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.031 · Cited by 295 · see citing works

Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters

Gelperina, S. E., Maksimenko, O., Khalansky, A. S., Vanchugova, L. V., Шипуло, Е. В., Abbasova, K., Berdiev, R. K., Wohlfart, S., Chepurnova, N. E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.003 · Cited by 293 · see citing works

The Blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System

Begley, D. J. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb07112.x · Cited by 291 · see citing works

DNAzyme Targeting c- jun Suppresses Skin Cancer Growth

Cai, H., Santiago, F. S., Prado-Lourenço, L., Wang, B., Patrikakis, M., Davenport, M. P., Maghzal, G. J., Stocker, R., Parish, C. R., Chong, B. H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003960 · Cited by 282 · see citing works

Delivery of peptide and protein drugs over the blood–brain barrier

Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279 · see citing works

Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles

WILSON, B., Samanta, M. K., Santhi, K., KUMAR, K., Paramakrishnan, N., & Suresh, B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.009 · Cited by 279 · see citing works

Nanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier

Schröeder, U., Sommerfeld, P., Ulrich, S., & Sabel, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980084y · Cited by 275 · see citing works

The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer - poloxamine 908

Illum, L., Davis, S. S., Müller, R. H., Mak, E., & West, P. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90138-x · Cited by 273 · see citing works

Degradation of poly (isobutyl cyanoacrylate) nanoparticles

Lenaerts, V., Couvreur, P., Christiaens-Leyh, D., Joiris, E., Roland, M., Rollmann, B., & Speiser, P. P. (1984) · Biomaterials · doi:10.1016/0142-9612(84)90002-4 · Cited by 272 · see citing works

Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles

Gao, K., & Jiang, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.040 · Cited by 269 · see citing works

Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor

Prades, R., Guerrero, S., Araya, E., Molina-Pelayo, C., Salas‐Huenuleo, E., Zurita, E., Selva, J., Egea, G., López‐Iglesias, C., Teixidò, M., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.063 · Cited by 269 · see citing works

Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury

Reddy, M. K., & Labhasetwar, V. D. (2009) · The FASEB Journal · doi:10.1096/fj.08-116947 · Cited by 264 · see citing works

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain

Kreuter, J., Hekmatara, T., Dreis, S., Vogel, T., Gelperina, S. E., & Langer, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.012 · Cited by 263 · see citing works

Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model

Wagner, S., Zensi, A., Wien, S., Tschickardt, S., Maier, W., Vogel, T., Worek, F., Pietrzik, C. U., Kreuter, J., & von Briesen, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032568 · Cited by 260 · see citing works

Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)

Ulbrich, K., Knobloch, T., & Kreuter, J. (2011) · Journal of Drug Targeting · doi:10.3109/10611861003734001 · Cited by 259 · see citing works

Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine

Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Ramasamy, M., & Suresh, B. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.04.001 · Cited by 245 · see citing works

Uptake and transport of high‐density lipoprotein (HDL) and HDL‐associated α‐tocopherol by an in vitro blood–brain barrier model

Balázs, Z., Panzenboeck, U., Hammer, A., Sovic, A., Quehenberger, O., Malle, E., & Sattler, W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02373.x · Cited by 239 · see citing works

Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery

Trapani, A., De Giglio, E., Cafagna, D., Denora, N., Agrimi, G., Cassano, T., Gaetani, S., Cuomo, V., & Trapani, G. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.036 · Cited by 238 · see citing works

Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting

Brigger, I., Morizet, J., Aubert, G., Chacun, H., Terrier‐Lacombe, M., Couvreur, P., & Vassal, G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039669 · Cited by 234 · see citing works

Targeting the central nervous system: In vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123

Tosi, G., Costantino, L., Rivasi, F., Ruozi, B., Leo, E., Vergoni, A. V., Tacchi, R., Bertolini, A., Vandelli, M. A., & Forni, F. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.022 · Cited by 234 · see citing works

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80–coated polybutylcyanoacrylate nanoparticles: Anin situbrain perfusion study

Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229 · see citing works

Topics in Pharmaceutical Sciences

Yalkowsky, S. H. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600720233 · Cited by 221 · see citing works

Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles

Kurakhmaeva, K. B., Djindjikhashvili, I. A., Petrov, V. E., Balabanyan, V. U., Voronina, T. A., Trofimov, S. S., Kreuter, J., Gelperina, S., Begley, D., & Alyautdin, R. N. (2009) · Journal of Drug Targeting · doi:10.1080/10611860903112842 · Cited by 221 · see citing works

Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded Nanoparticles

Couvreur, P., Kante, B., Grislain, L., Roland, M., & Speiser, P. P. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710717 · Cited by 217 · see citing works

Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain

Sun, W., Xie, C., Wang, H., & Hu, Y. L. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.087 · Cited by 215 · see citing works

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

Olivier, J.-C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., & Couet, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018947208597 · Cited by 213 · see citing works

Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier

Costantino, L., Gandolfi, F., Tosi, G., Rivasi, F., Vandelli, M. A., & Forni, F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.013 · Cited by 208 · see citing works

Transcytosis of plasma macromolecules in endothelial cells: A cell biological survey

Simionescu, M., Gafencu, A. V., & Antohe, F. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10086 · Cited by 207 · see citing works

Reengineering Biopharmaceuticals for Targeted Delivery Across the Blood–Brain Barrier

Pardridge, W. M., & Boado, R. J. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-396962-0.00011-2 · Cited by 199 · see citing works

Polysorbate‐80 coating enhances uptake of polybutylcyanoacrylate (PBCA)‐nanoparticles by human and bovine primary brain capillary endothelial cells

Ramge, P., Unger, R. E., Oltrogge, J. B., Zenker, D., Begley, D. J., Kreuter, J., & von Briesen, H. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00078.x · Cited by 197 · see citing works

Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles

Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196 · see citing works

ABCA1 and Scavenger Receptor Class B, Type I, Are Modulators of Reverse Sterol Transport at an in Vitro Blood-Brain Barrier Constituted of Porcine Brain Capillary Endothelial Cells

Panzenboeck, U., Balázs, Z., Sovic, A., Hrzenjak, A., Levak‐Frank, S., Wintersperger, A., Malle, E., & Sattler, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207601200 · Cited by 196 · see citing works

Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles

Lin, X., Tian, Wei, Feng, Huang, Wang, Ren, R., & Diao (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16570 · Cited by 189 · see citing works

A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection

Karataş, H., Aktaş, Y., Özdemir, Y., Bodur, E., Yemişçi, M., Caban-Toktas, S., Vural, A., Pınarbaşlı, O., Çapan, Y., Fernández-Megía, E., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4246-09.2009 · Cited by 187 · see citing works

Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma

Gelperina, S. E., Khalansky, A. S., Skidan, I. N., Smirnova, Z. S., Bobruskin, A. I., Severin, E. S., Turowski, B., Zanella, F., & Kreuter, J. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00456-8 · Cited by 185 · see citing works

In Situ Blood–Brain Barrier Transport of Nanoparticles

Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003374.58641.62 · Cited by 182 · see citing works

Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (bbb).

Kreuter, J. (2013) · Journal of Microencapsulation · doi:10.3109/02652048.2012.692491 · Cited by 172 · see citing works

Preparation, characterization,in vivoand biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model

Yusuf, M., Khan, M., Khan, R. A., & Ahmed, B. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.747529 · Cited by 171 · see citing works

Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrierin vivoandin vitro

Alyaudtin, R. N., Reichel, A., Löbenberg, R., Ramge, P., Kreuter, J., & Begley, D. J. (2001) · Journal of drug targeting · doi:10.3109/10611860108997929 · Cited by 166 · see citing works

Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers

Wohlfart, S., Khalansky, A. S., Gelperina, S. E., Maksimenko, O., Bernreuther, C., Glatzel, M., & Kreuter, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019121 · Cited by 162 · see citing works

Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants

Tröster, S. D., Müller, U., & Kreuter, J. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90047-8 · Cited by 161 · see citing works

Quinoline‐n‐butylcyanoacrylate‐based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease

Kulkarni, P. V., Roney, C. A., Antich, P. P., Bonte, F. J., Raghu, A. V., & Aminabhavi, T. M. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.59 · Cited by 159 · see citing works

Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length

Lherm, C., Müller, R. H., Puisieux, F., & Couvreur, P. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90210-s · Cited by 159 · see citing works

Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

Bickel, U., Yoshikawa, T., Landaw, E. M., Faull, K. F., & Pardridge, W. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2618 · Cited by 157 · see citing works

Transport of stavudine, delavirdine, and saquinavir across the blood–brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles

KUO, Y., & SU, F. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.012 · Cited by 147 · see citing works

Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers

Geldenhuys, W. J., Mbimba, T., Bui, T., Harrison, K. A., & Sutariya, V. B. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.589435 · Cited by 144 · see citing works

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system

Friese, A. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00073-9 · Cited by 140 · see citing works

Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation

Xin, H., Chen, L., Gu, J., Ren, X., wei, Z., Luo, J., Chen, Y., Jiang, X., Sha, X., & Fang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.005 · Cited by 137 · see citing works

Do anticancer agents reach the tumor target in the human brain?

Donelli, M. G., Zucchetti, M., & D’Incalci, M. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686291 · Cited by 137 · see citing works

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

Ambruosi, A., Khalansky, A. S., Yamamoto, H., Gelperina, S. E., Begley, D. J., & Kreuter, J. (2006) · Journal of drug targeting · doi:10.1080/10611860600636135 · Cited by 134 · see citing works

In Vivo Methods to Study Uptake of Nanoparticles into the Brain

van Rooy, I., Cakir-Tascioglu, S., Hennink, W. E., Storm, G., Schiffelers, R. M., & Mastrobattista, E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0291-7 · Cited by 132 · see citing works

Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model

Wang, C., Le-song, H., Hou, L., Jiang, L., Yan, Z.-T., Wang, Y.-L., & Chen, Z.-L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.011 · Cited by 129 · see citing works

Endothelial transcytosis in health and disease

Simionescu, M., Popov, D., & Sima, A. V. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0688-3 · Cited by 127 · see citing works

Functional Protein Delivery into Neurons Using Polymeric Nanoparticles

Hasadsri, L., Kreuter, J., Hattori, H., Iwasaki, T., & George, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805956200 · Cited by 127 · see citing works

Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain

Zensi, A., Begley, D. J., Pontikis, C., Legros, C., Mihoreanu, L., Büchel, C., & Kreuter, J. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.513712 · Cited by 119 · see citing works

Influence of the Surfactant Concentration on the Body Distribution of Nanoparticles

Araújo, L. C. D. P., Löbenberg, R., & Kreuter, J. (1999) · Journal of drug targeting · doi:10.3109/10611869908996844 · Cited by 119 · see citing works

Transferrin Adsorption onto PLGA Nanoparticles Governs Their Interaction with Biological Systems from Blood Circulation to Brain Cancer Cells

Chang, J., Paillard, A., Passirani, C., Morille, M., Benoît, J., Betbeder, D., & Garcion, E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0624-1 · Cited by 115 · see citing works

Bio-Nanotechnology: A Revolution in Food, Biomedical and Health Sciences

Bagchi, D., Bagchi, M., Moriyama, H., et al. (2012) · Cited by 114 · see citing works

Effects of Surface Modification on Delivery Efficiency of Biodegradable Nanoparticles Across The Blood–Brain Barrier

Kulkarni, S. A., & Feng, S. (2011) · Nanomedicine · doi:10.2217/nnm.10.131 · Cited by 110 · see citing works

Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrier

Chen, Y., Hsieh, W.-Y., Lee, W., & Zeng, D.-T. (2011) · Journal of Biomaterials Applications · doi:10.1177/0885328211429495 · Cited by 105 · see citing works

Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers

Borchard, G., Audus, K. L., Shi, F., & Kreuter, J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90372-7 · Cited by 105 · see citing works

Negative preclinical results with stealth® nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model

Brigger, I., Morizet, J., Laudani, L., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.019 · Cited by 100 · see citing works

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model

Ambruosi, A., Gelperina, S. E., Khalansky, A. S., Tanski, S., Theisen, A., & Kreuter, J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600788080 · Cited by 100 · see citing works

Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier

Wohlfart, S., Khalansky, A. S., Gelperina, S. E., Begley, D. J., & Kreuter, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.010 · Cited by 100 · see citing works

Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model

Çırpanlı, Y., Allard-Vannier, É., Passirani, C., Bilensoy, E., Lemaire, L. P., Çalış, S., & Benoît, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.015 · Cited by 99 · see citing works

Polymeric nanoparticles and microspheres

Banakar, U. V. (1988) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600770123 · Cited by 99 · see citing works

Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery Across The Blood–Brain Barrier

Tosi, G., Fano, R. A., Bondioli, L., Badiali, L., Benassi, R., Rivasi, F., Ruozi, B., Forni, F., & Vandelli, M. A. (2011) · Nanomedicine · doi:10.2217/nnm.11.11 · Cited by 99 · see citing works

Specific delivery of mitomycin c to the liver, spleen and lung: Nano- and m1crospherical carriers of gelatin

Yoshioka, T., Hashida, M., Muranishi, S., et al. (1981) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(81)90017-x · Cited by 96 · see citing works

Nanoparticle-Based in Vivo Investigation on Blood−Brain Barrier Permeability Following Ischemia and Reperfusion

Yang, C., Chang, C.-H., Tsai, P., Chen, W., Tseng, F., & Lo, L. (2004) · Analytical Chemistry · doi:10.1021/ac035491v · Cited by 95 · see citing works

Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles

Liu, M., Li, H., Luo, G., Liu, Q., & Wang, Y. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1191-8 · Cited by 94 · see citing works

Nanoparticles and nanocapsules--new dosage forms in the nanometer size range.

Kreuter, J. (1978) · PubMed · Cited by 93 · see citing works

Delivery of nanoparticles to the brain detected by fluorescence microscopy

Reimold, I., Domke, D., Bender, J., Seyfried, C. A., Radunz, H.-E., & Fricker, G. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.007 · Cited by 89 · see citing works

Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat

Wolburg, H., Wolburg‐Buchholz, K., Sam, H., Horvát, S., Deli, M. A., & Mack, A. F. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0410-2 · Cited by 85 · see citing works

Preparation and Therapeutic Efficacy of Polysorbate-80-Coated Amphotericin B/PLA-b-PEG Nanoparticles

Ren, T., Xu, N., Cao, C., Yuan, W., Xiao, Y., Chen, J., & Ren, J. (2009) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/092050609x12457418779185 · Cited by 80 · see citing works

Body distribution of polysorbate‐80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats

Ambruosi, A., Yamamoto, H., & Kreuter, J. (2005) · Journal of drug targeting · doi:10.1080/10611860500411043 · Cited by 79 · see citing works

Methotrexate-Loaded Chitosan- and Glycolchitosan-Based Nanoparticles: A Promising Strategy for the Administration of the Anticancer Drug to Brain Tumors

Trapani, A., Denora, N., Iacobellis, G., et al. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9695-x · Cited by 77 · see citing works

Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats

Maincent, P., Thouvénot, P., Amicabile, C., Hoffman, M., Kreuter, J., Couvreur, P., & Devissaguet, J. P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015895804597 · Cited by 76 · see citing works

Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: Focus on cardio- and testicular toxicity

Переверзева, Э. Р., Трещалин, И. Д., Бодягин, Д. А., Максименко, О. О., Langer, K., Dreis, S., Asmussen, B., Kreuter, J., & Gelperina, S. E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.031 · Cited by 76 · see citing works

Design and Evaluation of Chitosan Nanoparticles As Novel Drug Carrier for the Delivery of Rivastigmine to Treat Alzheimer‘s Disease

Wilson, B., Samanta, M. K., Muthu, M. S., & Vinothapooshan, G. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.21 · Cited by 74 · see citing works

Molecular Weights of Free and Drug-Loaded Nanoparticles

Vansnick, L., Couvreur, P., Christiaens-Leyh, D., & Roland, M. (1985) · Pharmaceutical Research · doi:10.1023/a:1016366022712 · Cited by 72 · see citing works

Macrophage Targeting of Azidothymidine: A Promising Strategy for AIDS Therapy*

Löbenberg, R., & Kreuter, J. (1996) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1996.12.1709 · Cited by 70 · see citing works

Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles

Schneider, T. L., Becker, A., Ringe, K., Reinhold, A., Firsching, R. P., & Sabel, B. A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.12.005 · Cited by 69 · see citing works

Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model

Wagner, S., Kufleitner, J., Zensi, A., Dadparvar, M., Wien, S., Bungert, J., Vogel, T., Worek, F., Kreuter, J., & von Briesen, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014213 · Cited by 69 · see citing works

Degradation of poly(?-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII)

Landry, F. (1996) · Biomaterials · doi:10.1016/0142-9612(96)86742-1 · Cited by 68 · see citing works

Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain

Parikh, T., Bommana, M. M., & Squillante, E. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.11.001 · Cited by 66 · see citing works

Body distribution of 3HH-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after I.V. injections to mice

Schröeder, U., Schröeder, H., & Sabel, B. A. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00619-0 · Cited by 66 · see citing works

Treatment of 9L Gliosarcoma in Rats by Ferrociphenol-Loaded Lipid Nanocapsules Based on a Passive Targeting Strategy via the EPR Effect

Huynh, N. T., Morille, M., Bejaud, J., Legras, P., Vessières, A., Jaouen, G., Benoît, J., & Passirani, C. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0501-y · Cited by 64 · see citing works

Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects

Hekmatara, T., Bernreuther, C., Khalansky, A. S., Theisen, A., Weissenberger, J., Matschke, J., Gelperina, S. E., Kreuter, J., & Glatzel, M. (2009) · Clinical Neuropathology · doi:10.5414/npp28153 · Cited by 61 · see citing works

Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages

Schäfer, V., von Briesen, H., Rübsamen‐Waigmann, H., Steffan, A., Royer, C., & Kreuter, J. (1994) · Journal of Microencapsulation · doi:10.3109/02652049409040455 · Cited by 60 · see citing works

Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles

Bender, A., Schäfer, V., Steffan, A., Royer, C., Kreuter, J., Rübsamen‐Waigmann, H., & von Briesen, H. (1994) · Research in Virology · doi:10.1016/s0923-2516(07)80025-2 · Cited by 60 · see citing works

Significant delivery of tacrine into the brain using magnetic chitosan microparticles for treating Alzheimer's disease

Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Ramasamy, M., & Suresh, B. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.10.036 · Cited by 60 · see citing works

Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain

Lin, Y., Pan, Y., Shi, Y., Huang, X., Jia, N., & Jiang, J. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/16/165101 · Cited by 60 · see citing works

Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles

Scherer, D., Robinson, J. R., & Kreuter, J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90086-8 · Cited by 59 · see citing works

Influence of the surface properties of low contact angle surfactants on the body distribution of14C-poly(methyl methacrylate) nanoparticles

Tröster, S. D., & Kreuter, J. (1992) · Journal of Microencapsulation · doi:10.3109/02652049209021219 · Cited by 59 · see citing works

Can Leptin-Derived Sequence-Modified Nanoparticles Be Suitable Tools for Brain Delivery?

Tosi, G., Badiali, L., Ruozi, B., Vergoni, A. V., Bondioli, L., Ferrari, A., Rivasi, F., Forni, F., & Vandelli, M. A. (2011) · Nanomedicine · doi:10.2217/nnm.11.98 · Cited by 52 · see citing works

Understanding and circumventing the blood‐brain barrier

Begley, D. J. (2003) · Acta Paediatrica · doi:10.1111/j.1651-2227.2003.tb00226.x · Cited by 50 · see citing works

Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays

Juan, B. S. D., von Briesen, H., Gelperina, S. E., & Kreuter, J. (2006) · Journal of drug targeting · doi:10.1080/10611860600866872 · Cited by 49 · see citing works

Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats

Переверзева, Э. Р., Трещалин, И. Д., Бодягин, Д. А., Максименко, О. О., Kreuter, J., & Gelperina, S. E. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.01.020 · Cited by 47 · see citing works

Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles

Wohlfart, S., Khalansky, A. S., Bernreuther, C., Michaelis, M., Cinatl, J. J., Glatzel, M., & Kreuter, J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.046 · Cited by 47 · see citing works

Delivery of peptides and proteins through the blood-brain barrier

Bickel, U., Yoshikawa, T., & Pardridge, W. M. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90048-9 · Cited by 47 · see citing works

Influence of Nanoparticles on the Brain-to-serum Distribution and the Metabolism of Valproic Acid in Mice

Darius, J., Meyer, F. P., Sabel, B. A., & Schröeder, U. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774958 · Cited by 45 · see citing works

FDA and Nanotech: Baby Steps Lead to Regulatory Uncertainty

Bawa, R. (2013) · doi:10.1002/9781118451915.ch41 · Cited by 38 · see citing works

Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: The example of Alzheimer's disease

Andrieux, K., & Couvreur, P. (2013) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2013.04.001 · Cited by 37 · see citing works

Molecular weights of polycyanoacrylate nanoparticles

El-Egakey, M. A. A. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90084-4 · Cited by 35 · see citing works

Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles1

Huang, M., Wu, W., Jun, Q. I. A. N., Dan-jing, W., Wei, X., & Zhu, J. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00216.x · Cited by 34 · see citing works

Circadian Phase-Dependent Antinociceptive Reaction in Mice Determined by the Hot-Plate test and the Tail-Flick Test After Intravenous Injection of Dalargin-Loaded Nanoparticles

Ramge, P., Kreuter, J., & Lemmer, B. (1999) · Chronobiology International · doi:10.3109/07420529909016944 · Cited by 27 · see citing works

Intracellular drug delivery using polysorbate 80-modified poly( D , L -lactide-co-glycolide) nanospheres to glioblastoma cells

Tahara, K., Kato, Y., Yamamoto, H., Kreuter, J., & Kawashimà, Y. (2010) · Journal of Microencapsulation · doi:10.3109/02652048.2010.522258 · Cited by 25 · see citing works

Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles

Kang, C. (2011) · Oncology Reports · doi:10.3892/or.2011.1459 · Cited by 25 · see citing works

Molecular weights of poly(butyl 2‐cyanoacrylate) produced during nanoparticle formation

Douglas, S. J., Davis, S. S., & Holding, S. R. (1985) · British Polymer Journal · doi:10.1002/pi.4980170404 · Cited by 23 · see citing works

Brain Superhighways

Begley, D. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004611 · Cited by 23 · see citing works

Body Distribution of75Se-Radiolabeled Silica Nanoparticles Covalently Coated with co-functionalized Surfactants After Intravenous Injection in Rats

Borchardt, G., Brandriss, S., Kreuter, J., et al. (1994) · Journal of drug targeting · doi:10.3109/10611869409015894 · Cited by 21 · see citing works

7 Nanoparticles as drug carriers

Tadros Tharwat, F. (2018) · Spark · doi:10.1515/spark.43.8 · Cited by 20 · see citing works

ONTOGENY OF THE ULTRADIAN RHYTHM OF ACTIVITY IN JAPANESE QUAIL

Lumineau, S., Guyomarc’h, C., & Richard, J. (2000) · Chronobiology International · doi:10.1081/cbi-100102112 · Cited by 18 · see citing works

Nanoparticles as Drug Delivery Systems

Xing, H. (2003) · Journal of Huaihua University · Cited by 18 · see citing works

Comparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice).

Petkov, V. D., Mosharrof, A. H., & Petkov, V. V. (1988) · PubMed · Cited by 12 · see citing works

Increased Numbers of Injections of Doxorubicin Bound to Nanoparticles Lead to Enhanced Efficacy Against Rat Glioblastoma 101/8

Wohlfart, S., Bernreuther, C., Khalansky, A. S., Theisen, A., Weissenberger, J., Gelperina, S. E., Glatzel, M., & Kreuter, J. (2009) · Journal of Nanoneuroscience · doi:10.1166/jns.2009.1003 · Cited by 11 · see citing works

In vitro release performance and analgesic activity of endomorphin-1 loaded nanoparticles.

Liu, H., Ni, J., & Wang, R. (2006) · PubMed · Cited by 11 · see citing works

Nanoparticulate Carriers for Drug Delivery to the Brain

Kreuter, J. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860949074_0024 · Cited by 11 · see citing works

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609 · see citing works

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model

Cano, A., Ettcheto, M., Chang, J.-H., Barroso, E., Espina, M., Kühne, B. A., Barenys, M., Auladell, C., Folch, J., Souto, E. B., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.010 · Cited by 337 · see citing works

Breaking Down the Barriers to Precision Cancer Nanomedicine

von Roemeling, C., Jiang, W., Chan, C. K., Weissman, I. L., & Kim, B. Y. S. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.07.006 · Cited by 330 · see citing works

Strategies for transporting nanoparticles across the blood–brain barrier

Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W. (2016) · Biomaterials Science · doi:10.1039/c5bm00383k · Cited by 308 · see citing works

State of the art challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications

Seabra, A. B., Justo, G. Z., & Haddad, P. S. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.01.005 · Cited by 151 · see citing works

The potential of protein–nanomaterial interaction for advanced drug delivery

Peng, Q., & Mu, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.041 · Cited by 134 · see citing works

Neurotheranostics as Personalized Medicines

Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124 · see citing works

Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation

Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125 · see citing works

Nanoparticle technology for treatment of Parkinson’s disease: The role of surface phenomena in reaching the brain

Leyva-Gómez, G., Cortés, H., Magaña, J. J., Leyva-García, N., Quintanar-Guerrero, D., & Florán, B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.009 · Cited by 102 · see citing works

Ultrabright Fluorescent Polymeric Nanoparticles with a Stealth Pluronic Shell for Live Tracking in the Mouse Brain

Khalin, I., Heimburger, D., Melnychuk, N., Collot, M., Groschup, B., Hellal, F., Reisch, A., Plesnila, N., & Klymchenko, A. S. (2020) · ACS Nano · doi:10.1021/acsnano.0c01505 · Cited by 82 · see citing works

Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery

Joshi, C. R., Labhasetwar, V., & Ghorpade, A. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9724-3 · Cited by 55 · see citing works

Brief Outlook on Polymeric Nanoparticles, Micelles, Niosomes, Hydrogels and Liposomes: Preparative Methods and Action

Joy, R., George, J., & John, F. (2022) · ChemistrySelect · doi:10.1002/slct.202104045 · Cited by 50 · see citing works

Nanocarriers as cns drug delivery systems for enhanced neuroprotection

Ozkizilcik, A., Davidson, P., Turgut, H., Sharma, H. S., Sharma, A., & Tian, Z. R. (2017) · Drug and Gene Delivery to the Central Nervous System for Neuroprotection · doi:10.1007/978-3-319-57696-1_2 · Cited by 10 · see citing works

Exploring the Blood Brain Barrier: Structure, Function, and Medical Implications

Roberts, J., & Huang, J. V. (2021) · Journal of Student Research · doi:10.47611/jsrhs.v10i4.2271 · Cited by 1 · see citing works

Adsorptive-Mediated Brain Delivery Systems

Lü, W. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112803341851 · Cited by 129 · see citing works

Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation

Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549 · see citing works

Intracellular transport and regulation of transcytosis across the blood–brain barrier

Villaseñor, R., Lampe, J., Schwaninger, M., & Collin, L. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2982-x · Cited by 210 · see citing works

Drug delivery through the blood-brain barrier

Tamai, I., & Tsuji, A. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00011-7 · Cited by 101 · see citing works